FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer

Published:2015-03-09 Issue:11 Volume:21 Page:2436-2439
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Khozin Sean,Blumenthal Gideon M.,Zhang Lijun,Tang Shenghui,Brower Margaret,Fox Emily,Helms Whitney,Leong Ruby,Song Pengfei,Pan Yuzhuo,Liu Qi,Zhao Ping,Zhao Hong,Lu Donghao,Tang Zhe,Al Hakim Ali,Boyd Karen,Keegan Patricia,Justice Robert,Pazdur Richard

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDA-approved small molecule kinase inhibitors for cancer treatment (2001–2015): Medical indication, structural optimization, and binding mode Part I;Bioorganic & Medicinal Chemistry;2024-09

2. A Phosphoramidate Prodrug Platform: One‐Pot Amine Functionalization of Kinase Inhibitors with Oligoethylene Glycol for Improved Water‐Solubility;Chemistry – A European Journal;2024-08-12

3. Population pharmacokinetics and exposure–response analyses of SAF-189s in Chinese patients with ALK+/ROS1+ non-small cell lung cancer;Frontiers in Pharmacology;2024-07-16

4. Artificial Neural Network Models for Solution Concentration Measurement during Cooling Crystallization of Ceritinib;Tehnički glasnik;2024-07-15

5. Atrioventricular re-entrant tachycardia and atrioventricular node re-entrant tachycardia in a patient with cancer under chemotherapy: a case report and literature review;Frontiers in Cardiovascular Medicine;2024-06-07